Back to search
Human Cytomegalovirus (HCMV)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Human Cytomegalovirus (HCMV) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Human Cytomegalovirus (HCMV) trials you may qualify forHuman cytomegalovirus (HCMV) establishes a lifelong relationship with its host: primary infection is followed by a latency phase with intermittent reactivation…
The main purpose of the study is to evaluate the efficacy and safety of mRNA-1647 compared to placebo to prevent first clinically significant cytomegalovirus in…
This is an interventional, open-label, single center, pilot study with historical controls to test the efficacy of letermovir (LET) for the prevention of CMV in…
Human cytomegalovirus (HCMV) infection is one of the most common and serious complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT).…
The main purpose of the study is to evaluate the safety and immunogenicity of SPYVLP01 in two different doses with and without adjuvants in healthy adults aged…